Manatsawee Manopunya

Mr. Manatsawee Manopunya

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
TKTae-Wook Kong
Tae-Wook Kong
HRHee-Sug Ryu
Hee-Sug Ryu
SKSeung Cheol Kim
Seung Cheol Kim
TETakayuki Enomoto
Takayuki Enomoto
JLJin Li
Jin Li
SJSeob Jeon
Seob Jeon
Kong TW, et al. J Gynecol Oncol. 2018 Aug;30:e39. https://doi.org/10.3802/jgo.2019.30.e39

1 March 2021 in Medicina
Verified
Journal Article
Open access
PDF file
KTKuntharee Traisrisilp
Kuntharee Traisrisilp
MMManatsawee Manopunya
Manatsawee Manopunya
TSTanop Srisuwan
Tanop Srisuwan
WCWisit Chankhunaphas
Wisit Chankhunaphas
TTTheera Tongsong
Theera Tongsong
This study aims to emphasize that asymptomatic patients with undiagnosed and asymptomatic May-Thurner syndrome (MTS) may firstly develop severe compression during pregnancy. A 40-year-old woman, G1P0, at 22 weeks of twin gestation presented with left lower extremity edema and pain. One twin was structurally normal while the other had bilateral renal agenesis with oligohydramnios. Magnetic resonance venography (MRV) revealed severe compression of the left iliac vein by the right iliac artery without evidence of deep vein thrombosis (DVT). Conservative treatment with anticoagulant prophylaxis was instituted throughout the rest of pregnancy and postpartum period. She was also complicated with severe pre-eclampsia, a cesarean section was performed due to a prolapsed cord at 27 weeks of gestation, and she gave birth to a surviving baby weighing 1100 g. In conclusion, this case report provides evidence that pregnancy can disclose a subtle May-Thurner anatomy to be symptomatic without DVT. Successful pregnancy outcomes could be achieved with conservative treatment and anticoagulant prophylaxis.

11 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RPRattiya Phianpiset
Rattiya Phianpiset
CDChayanid Detwongya
Chayanid Detwongya
SPSunisa Phookiaw
Sunisa Phookiaw
MMManatsawee Manopunya
Manatsawee Manopunya
CPChailert Phongnarisorn
Chailert Phongnarisorn
Kittipat CharoenkwanKittipat Charoenkwan
Kittipat Charoenkwan
Objective: To assess the oncological outcomes of laparoscopic versus open radical hysterectomy (RH) in patients with early-stage cervical cancer using propensity score–matched analysis. Methods: We conducted a retrospective cohort study of 1244 patients who underwent RH with pelvic lymphadenectomy at Chiang Mai University Hospital between 2003 and 2019. Of these, 82 patients received a laparoscopic approach (LAP) and 1162 underwent open radical hysterectomy. Propensity-score matching was performed in a 1:4 ratio using a caliper of 0.2 standard deviations to achieve balance between groups. Overall survival (OS) and progression-free survival (PFS) were analyzed with Kaplan–Meier curves and the log-rank test. Subgroup analysis was conducted based on tumor size (≤ 2 cm vs. > 2 cm). In addition, multivariable Cox proportional hazards models incorporating all relevant clinical and pathological variables were applied to the overall cohort to assess independent predictors of OS and PFS. Results: After matching, 72 LAP RH cases were compared with 279 open RH cases, showing well-balanced baseline features. At 5 years, OS was nearly the same between the LAP and the open groups (95.8% vs. 95.5%; p = 0.95), and PFS was also similar (92.3% vs. 93.8%; p = 0.85). Subgroup analyses demonstrated that LAP RH did not result in a survival disadvantage for tumors ≤ 2 cm or > 2 cm. In multivariable Cox analysis, surgical approach was not an independent predictor of (HR 0.83, 95% CI 0.40–1.71, p = 0.61) or PFS (HR 1.12, 95% CI 0.44–2.84, p = 0.82). Conclusions: In our single-center cohort analyzed using propensity score matching, LAP RH showed long-term oncological outcomes comparable to those of open RH. These results support LAP RH as a safe surgical option for selected patients with early-stage cervical cancer within our setting, where procedures were performed by experienced surgeons following standardized techniques. Further evaluation in diverse clinical contexts is still needed.

1 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
RPRattiya Phianpiset
Rattiya Phianpiset
CDChayanid Detwongya
Chayanid Detwongya
MMManatsawee Manopunya
Manatsawee Manopunya
Chalong CheewakriangkraiChalong Cheewakriangkrai
Chalong Cheewakriangkrai
Kittipat CharoenkwanKittipat Charoenkwan
Kittipat Charoenkwan
Background: Radical hysterectomy with pelvic lymphadenectomy is a standard surgical procedure for early-stage cervical cancer. However, even with optimal treatment, some patients still experience disease recurrence. We aimed to develop and validate a prediction model to classify patients according to the risk of recurrence which can better assist clinicians to tailor the postoperative treatment and improve patient outcomes. Methods: Data of women diagnosed with early-stage cervical cancer who underwent radical hysterectomy were collected and analyzed. The primary outcome was recurrence-free survival (RFS). A prediction model based on Cox proportional hazard regression was developed by using the backward elimination procedure. Internal validation was performed by bootstrapping. The model’s discriminative ability was demonstrated by the concordance index (C-index). The model’s calibration was examined through a calibration plot. The final prognostic model was presented as a nomogram and a web-based calculator, which were further used to categorize patients into low, moderate, and high-risk groups for clinical application. Results: Among the 1309 patients, 115 (8.8%) experienced a recurrence. The median follow-up was 72.2 months. The 3-year and 5-year RFS rates were 93.0% (95% CI, 91.5–94.6%) and 90.7% (95% CI, 88.9–92.5%), respectively. Tumor size, histological subtype, number of positive lymph nodes, lymphovascular space invasion, and platelet-to-lymphocyte ratio were significantly associated with RFS. These factors were employed to construct a prediction model. The model exhibited a good overall fit with minimal overfitting and good calibration. The model’s discriminative performance, as measured by the C-index, was 0.73. Conclusions: Our proposed survival model offers a potentially valuable tool for therapeutic decision-making in patients with early-stage cervical cancer. This model demonstrates robust discriminative performance and predictive calibration. Nevertheless, external validation across diverse datasets should be conducted to assess the reproducibility and applicability of this predictive model across a broader spectrum of patients.